Studsvik AB (publ) (STO:SVIK)

Sweden flag Sweden · Delayed Price · Currency is SEK
188.00
-7.00 (-3.59%)
Aug 1, 2025, 5:29 PM CET
-3.59%
Market Cap1.55B
Revenue (ttm)902.82M
Net Income (ttm)10.20M
Shares Out8.22M
EPS (ttm)1.24
PE Ratio151.48
Forward PE25.98
Dividend2.00 (1.03%)
Ex-Dividend DateApr 25, 2025
Volume14,536
Average Volume24,998
Open193.00
Previous Close195.00
Day's Range187.00 - 194.00
52-Week Range105.50 - 246.00
Beta0.89
RSI50.20
Earnings DateJul 22, 2025

About CTI BioPharma

Studsvik AB (publ) provides technical solutions across the nuclear and radioactive material lifecycle in Sweden, Germany, rest of Europe, Asia, North America, and internationally. It offers decommissioning and radiation protection services in the areas of radiation protection, engineering, decommissioning, dismantling, and decontamination; and fuel and materials technology services, such as fuel qualification, plant life management, international programs, final storage research, hot cell technology, and transport of irradiated materials, as we... [Read more]

Founded 1947
Employees 540
Stock Exchange Nasdaq Stockholm
Ticker Symbol SVIK
Full Company Profile

Financial Performance

In 2024, Studsvik AB's revenue was 893.12 million, an increase of 8.12% compared to the previous year's 826.03 million. Earnings were 9.60 million, a decrease of -80.24%.

Financial Statements

News

Swiss Investor Boosts Stake in Studsvik With ‘Growth Agenda’

Swiss investor Daniel Aegerter has boosted his stake in the Swedish nuclear technical services firm Studsvik AB to just under 30% and is pursuing an “ambitious growth agenda” amid a resurgence in the ...

6 weeks ago - Financial Post